Target Selectivity of Dasatinib (BMS-354825)
| Key Target | IC50 | Description | Reference |
|---|---|---|---|
| IbW5I= supersomes | 0.065 nM | IbW5I= supersomes inhibition assay | PMC8820617 |
| FYN | 0.2 nM | Kinase activity assay | PMC3397956 |
| LCK | 0.4 nM | Kinase inhibition assay | PMC8194179 |
| Src | 0.4 nM | Kinase inhibition assay | PMC8194179 |
| YES | 0.41 nM | Kinase activity assay | PMC3397956 |
| K562 cell lysates (Bcr-Abl) | 433.7 pM | eSimoa assay | PMC7472518 |
| Src (purified recombinant protein) | 466.7 pM | eSimoa assay | PMC7472518 |
| Bcr-Abl | 0.55 nM | Kinase activity assay (for isolated kinases) | PMC3388011 |
| ABL H396P | 0.6 nM | cellular assays | PMC12961899 |
| Abl (purified recombinant protein) | 735.1 pM | eSimoa assay | PMC7472518 |
| SRC | 0.8 nM | cellular assays | PMC12961899 |
| ABL WT | 0.8 nM | cellular assays | PMC12961899 |
| Src | 1 nM | Kinase inhibition assay (implied) | PMC9967321 |
| Lck | 1 nM | -- | PMC7352436 |
| BCR-Abl | 1 nM | Kinase inhibition assay (implied) | PMC9967321 |
| Fyn | 1 nM | -- | PMC7352436 |
| c-kit | 1 nM | Kinase inhibition assay (implied) | PMC9967321 |
| PDGFR | 1 nM | Kinase inhibition assay (implied) | PMC9967321 |
| Lck | 1 nM | Kinase inhibition assay (implied) | PMC9967321 |
| Fyn | 1 nM | Kinase inhibition assay (implied) | PMC9967321 |
| LCK | 1.1 nM | Kinase activity assay | PMC3397956 |
| ABL M351T | 1.1 nM | cellular assays | PMC12961899 |
| SRC | 1.2 nM | Kinase-Lumi Luminescent Kinase Assay Kit | PMC11677243 |
| ABL M244V | 1.3 nM | cellular assays | PMC12961899 |
| ABL Y253H | 1.3 nM | cellular assays | PMC12961899 |
| ABL H396R | 1.3 nM | cellular assays | PMC12961899 |
| ABL G250E | 1.8 nM | cellular assays | PMC12961899 |
| ABL F359V | 2.2 nM | cellular assays | PMC12961899 |
| ABL D276G | 2.6 nM | cellular assays | PMC12961899 |
| ABL E279K | 3.3 nM | cellular assays | PMC12961899 |
| ABL Q252H | 3.4 nM | cellular assays | PMC12961899 |
| AURKA/B/C | 4 nM | cellular assays | PMC12961899 |
| BCR–ABL Y253F | 5 nM | in vitro assays | PMC3825579 |
| E255 K/V | 5 nM | in vitro assays | PMC3825579 |
| F317L mutants | 5 nM | in vitro assays | PMC3825579 |
| ABL2 | 0.0055 µM | Competitive binding experiments with kinobeads, quantitative mass spectrometry, 10-plex tandem mass tags (TMT10), dose-response curves fitted using R and drc package, IC50 values corrected by experimentally-derived depletion factor. | PMC6775116 |
| ABL E255K | 5.6 nM | cellular assays | PMC12961899 |
| ABL F486S | 5.6 nM | cellular assays | PMC12961899 |
| podocytes (Focal Adhesions) | 5.9 nM | high-content image analysis | PMC12961899 |
| Src | 6 nM | ATP-dependent substrate phosphorylation assay (Z-lyte based assay) | PMC4869561 |
| ABL Y253F | 6.3 nM | cellular assays | PMC12961899 |
| ABL E255V | 6.3 nM | cellular assays | PMC12961899 |
| ABL F317L | 7.4 nM | cellular assays | PMC12961899 |
| Abl2 | 0.00741 µM | Kinome selectivity profiling, 8-plex proteomics experiments, kinobeads platform, dose-response curves. | PMC6775116 |
| PDGFRA WT | 13 nM | cellular assays | PMC12961899 |
| BCR–ABL T315I | 15 nM | in vitro assays | PMC3825579 |
| V299L mutants | 15 nM | in vitro assays | PMC3825579 |
| ABL V299L | 15.8 nM | cellular assays | PMC12961899 |
| ABL F317V | 17 nM | cellular assays | PMC12961899 |
| podocytes (cell shape and spreading area) | 18.5 nM | high-content image analysis | PMC12961899 |
| podocytes (nuclear architecture) | 20.4 nM | high-content image analysis | PMC12961899 |
| ABL1 | 22.12 nM | Kinase-Glo Plus luminescence assay | PMC12193096 |
| PDGFR | 28 nM | in vitro inhibition assay | PMC3397956 |
| KIT D816V | 37 nM | cellular assays | PMC12961899 |
| EPHA1 | 0.0575 µM | Competitive binding experiments with kinobeads, quantitative mass spectrometry, 10-plex tandem mass tags (TMT10), dose-response curves fitted using R and drc package, IC50 values corrected by experimentally-derived depletion factor. | PMC6775116 |
| PDGFRA V561D | 59 nM | cellular assays | PMC12961899 |
| PDGFRA D842V | 62 nM | cellular assays | PMC12961899 |
| KIT V559D | 74 nM | cellular assays | PMC12961899 |
| KIT WT | 79 nM | cellular assays | PMC12961899 |
| KIT V560G | 85 nM | cellular assays | PMC12961899 |
| PDGFRB WT | 114 nM | cellular assays | PMC12961899 |
| LYN | 128 nM | cellular assays | PMC12961899 |
| ABL T315I | 137 nM | cellular assays | PMC12961899 |
| ABL F311L | 140 nM | cellular assays | PMC12961899 |
| podocytes (cellular viability) | 253 nM | MTT viability assay on cultured podocytes | PMC12961899 |
| p38a | 378 nM | ATP-dependent substrate phosphorylation assay (Z-lyte based assay) | PMC4869561 |
| ABL L384M | 419.5 nM | cellular assays | PMC12961899 |
| ABL L387M | 492 nM | cellular assays | PMC12961899 |
| PDGFRA T674I | 500 nM | cellular assays | PMC12961899 |
| ABL T315A | 760 nM | cellular assays | PMC12961899 |
| PDGFRB T681I | 1000 nM | cellular assays | PMC12961899 |
| CYP2C8 | 7.2 µM | In vitro enzyme inhibition assay, IC50 calculated from Ki (Ki = IC50/2) | PMC8882081 |
| CYP3A4 (testosterone) | 10.0 µM | In vitro enzyme inhibition assay, IC50 calculated from Ki (Ki = IC50/2) | PMC8882081 |
| CYP3A4 (midazolam) | 18.0 µM | In vitro enzyme inhibition assay, IC50 calculated from Ki (Ki = IC50/2) | PMC8882081 |
| CYP1A2 | 35 µM | In vitro enzyme inhibition assay | PMC8882081 |
| CYP2A6 | 35 µM | In vitro enzyme inhibition assay | PMC8882081 |
| CYP2B6 | 35 µM | In vitro enzyme inhibition assay | PMC8882081 |
| CYPC9 | 35 µM | In vitro enzyme inhibition assay | PMC8882081 |
| CYP2C19 | 35 µM | In vitro enzyme inhibition assay | PMC8882081 |
| CYP2D6 | 35 µM | In vitro enzyme inhibition assay | PMC8882081 |
| CYP2E1 | 35 µM | In vitro enzyme inhibition assay | PMC8882081 |
| EGFRWT | 0.041 mM | EGFR Kinase Assay Kit, luminescence measurement | PMC12023740 |
| hVEGFR2 | 10 mM | Kinase activity assay (data from ChEMBL) | PMC3397956 |
| hp38a | 10 mM | Kinase activity assay (data from ChEMBL) | PMC3397956 |
| hp38b | 10 mM | Kinase activity assay (data from ChEMBL) | PMC3397956 |
| hp38d | 10 mM | Kinase activity assay (data from ChEMBL) | PMC3397956 |
| hp38g | 10 mM | Kinase activity assay (data from ChEMBL) | PMC3397956 |
| hSRC | 10 mM | Kinase activity assay (data from ChEMBL) | PMC3397956 |
| hEGFR | 10 mM | Kinase activity assay (data from ChEMBL) | PMC3397956 |
| hPDGFRb | 10 mM | Kinase activity assay (data from ChEMBL) | PMC3397956 |
| hFGFR1 | 10 mM | Kinase activity assay (data from ChEMBL) | PMC3397956 |
| hLCK | 10 mM | Kinase activity assay (data from ChEMBL) | PMC3397956 |
| hKIT | 10 mM | Kinase activity assay (data from ChEMBL) | PMC3397956 |
| hABL1 | 10 mM | Kinase activity assay (data from ChEMBL) | PMC3397956 |
| hHER2 | 10 mM | Kinase activity assay (data from ChEMBL) | PMC3397956 |
| hMEK1 | 10 mM | Kinase activity assay (data from ChEMBL) | PMC3397956 |
| hMEK2 | 10 mM | Kinase activity assay (data from ChEMBL) | PMC3397956 |
| hFYN | 10 mM | Kinase activity assay (data from ChEMBL) | PMC3397956 |
| hYES1 | 10 mM | Kinase activity assay (data from ChEMBL) | PMC3397956 |
| hCSF1R | 10 mM | Kinase activity assay (data from ChEMBL) | PMC3397956 |
| hEPHA2 | 10 mM | Kinase activity assay (data from ChEMBL) | PMC3397956 |
Check the
Dasatinib (BMS-354825)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Jump to
- Dasatinib (BMS-354825) Mechanism of Action: Src Kinase Inhibition in Senescent Cells Research
- Dasatinib (BMS-354825) Clinical Trials
- Dasatinib (BMS-354825) Working Concentration | Cell Culture | Treatment
- Dasatinib (BMS-354825) Solubility in DMSO
- Dasatinib (BMS-354825) Stock Solution
- Dasatinib (BMS-354825) Storage
- Dasatinib (BMS-354825) Stability
- Dasatinib (BMS-354825) Combination Database
- Dasatinib (BMS-354825) Molecular Weight
- Dasatinib (BMS-354825) SMILES
- Dasatinib (BMS-354825) CAS Number
- Dasatinib (BMS-354825) Chemical Structure (2D and 3D)
- Dasatinib (BMS-354825) IC50 for Cell-based and Cell-free Assays
- Dasatinib (BMS-354825) MedChemExpress (HY-10181)? Try a better option.
- Dasatinib (BMS-354825) Cayman (11498)? Try a better option.
- Dasatinib (BMS-354825) Sigma (SML2589)? Try a better option.
- Dasatinib (BMS-354825) Abmole (M1701)? Try a better option.
- Dasatinib (BMS-354825) Tocris (6793)? Try a better option.
- Dasatinib (BMS-354825) SDS|MSDS